Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology.

Hickman, L Brian; Stern, John M; Silverman, Daniel H S; Salamon, Noriko; Vossel, Keith.

Afiliação

Hickman LB; Mary S. Easton Center for Alzheimer's Research and Care, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
Stern JM; Department of Neurology, UCLA Seizure Disorder Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
Silverman DHS; Department of Neurology, UCLA Seizure Disorder Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
Salamon N; Mary S. Easton Center for Alzheimer's Research and Care, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
Vossel K; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Front Neurol ; 14: 1241638, 2023.

Article em En | MEDLINE | ID: mdl-37830092

Palavras-chave

Alzheimer dementia; amyloid; epileptic preclinical Alzheimer disease; epileptic prodromal Alzheimer disease; late onset epilepsy; late onset epilepsy of unknown etiology; late-onset amyloid Beta-related epilepsy; tau

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article